Brief Research Report

Published on 25 Sep 2023

Analysis of drug resistance in pulmonary tuberculosis patients with positive sputum tuberculosis culture in Northeast China

in Pharmacology of Infectious Diseases

Li Sichen
Wang Rui
Yang Yue
Liu Xin
Cui Youbin
Tang Ze
Cai Hongfei

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1263726

1,649 views

Original Research

Published on 22 Sep 2023

Optimizing tylosin dosage for co-infection of Actinobacillus pleuropneumoniae and Pasteurella multocida in pigs using pharmacokinetic/pharmacodynamic modeling

in Pharmacology of Infectious Diseases

Eon-Bee Lee
Muhammad Aleem Abbas
Jonghyun Park
Dereje D. Tassew
Seung-Chun Park

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1258403

3,996 views
1 citation

Editorial

Published on 18 Sep 2023

Editorial: Re-emergence of neglected tropical diseases amid the COVID-19 pandemic: epidemiology, transmission, mitigation strategies, and recent advances in chemotherapy and vaccines

in Pharmacology of Infectious Diseases

Ranjan K. Mohapatra
Venkataramana Kandi
Veronique Seidel
Ali A. Rabaan

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1265803

1,713 views
7 citations

Review

Published on 06 Sep 2023

Recent insights about pyrrolidine core skeletons in pharmacology

in Pharmacology of Infectious Diseases

Samet Poyraz
H. Ali Döndaş
Naciye Yaktubay Döndaş
José M. Sansano

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1239658

5,322 views
16 citations

Review

Published on 05 Sep 2023

Treatment of non-tuberculosis mycobacteria skin infections

in Pharmacology of Infectious Diseases

Xin-Yu Wang
Qian-Nan Jia
Jun Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1242156

10,058 views
4 citations

Perspective

Published on 24 Aug 2023

Efficacy and safety evaluation of Azvudine in the prospective treatment of COVID-19 based on four phase III clinical trials

in Pharmacology of Infectious Diseases

Ke-Wei Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1228548

3,410 views
4 citations

Original Research

Published on 15 Aug 2023

Bryum billardieri Schwaegr. against EV71 infection: in vitro and in vivo antiviral effects, identification of molecular mechanisms and active monomers

in Pharmacology of Infectious Diseases

Yun-Yu Wang
Qian Li
Xiu-Wei Han
Xin-Huan Wan
Li Zhang
Feng-Jv Niu
Yi-Zhou Xin
Chang-Zheng Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1164784

1,573 views

Original Research

Published on 08 Aug 2023

Evaluation of the effect of direct-acting antiviral agents on melatonin level and lipid peroxidation in chronic hepatitis C patients

in Pharmacology of Infectious Diseases

Nageh Ahmed El-Mahdy
Sabry Abou-Saif
Medhat Ismail Abd EL hamid
Heba M. Hashem
Mohamed Anwar Hammad
Sally El-Sayed Abu-Risha

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1128016

1,495 views

Review

Published on 31 Jul 2023

The brief overview, antivirus and anti-SARS-CoV-2 activity, quantitative methods, and pharmacokinetics of cepharanthine: a potential small-molecule drug against COVID-19

in Pharmacology of Infectious Diseases

Binbin Xia
Li Zheng
Yali Li
Wenfang Sun
Yang Liu
Liushui Li
Jingyao Pang
Jing Chen
Jiaxin Li
Hua Cheng

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1098972

2,518 views
4 citations

Review

Published on 27 Jul 2023

Navigating drug repurposing for Chagas disease: advances, challenges, and opportunities

in Pharmacology of Infectious Diseases

Exequiel O. J. Porta
Karunakaran Kalesh
Patrick G. Steel

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1233253

5,775 views
14 citations

Review

Published on 26 Jul 2023

Individualized antibiotic dosage regimens for patients with augmented renal clearance

in Pharmacology of Infectious Diseases

A-Xi Shi
Qiang Qu
Hai-Hui Zhuang
Xin-Qi Teng
Wei-Xin Xu
Yi-Ping Liu
Yi-Wen Xiao
Jian Qu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1137975

7,114 views
7 citations

Perspective

Published on 19 Jul 2023

Effectiveness of vonoprazan-based regimens compared with proton pump inhibitor-based regimens as first-line Helicobacter pylori agents

in Pharmacology of Infectious Diseases

Toshihiko Kakiuchi

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1216433

2,291 views

Brief Research Report

Published on 18 Jul 2023

Can BioSAXS detect ultrastructural changes of antifungal compounds in Candida albicans?–an exploratory study

in Pharmacology of Infectious Diseases

Kai Hilpert
Christoph Rumancev
Jurnorain Gani
Dominic W. P. Collis
Paula Matilde Lopez-Perez
Vasil M. Garamus
Ralf Mikut
Axel Rosenhahn

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1141785

1,565 views

Editorial

Published on 13 Jul 2023

Editorial: Global excellence in pharmacology of infectious diseases: Australia and Asia

in Pharmacology of Infectious Diseases

Kwang-sun Kim

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1243284

1,363 views

Editorial

Published on 13 Jul 2023

Editorial: Reviews in pharmacology of infectious diseases: 2022

in Pharmacology of Infectious Diseases

Hong Zhou
Esther Segal
Linda Boniface Oyama

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1236754

959 views

Original Research

Published on 30 Jun 2023

Evaluation of safety and effectiveness of remdesivir in treating COVID-19 patients after emergency use authorization study

in Pharmacology of Infectious Diseases

Erlina Burhan
Elisna Syahruddin
Fathiyah Isbaniah
Ginanjar Arum Desianti
Fanny Fachrucha
Cut Yulia Indah Sari
Efriadi Ismail
Puji Astuti
Muhammad Farhan Maruli
Farhan Mubarak

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1205238

2,842 views
2 citations

Navigation group

Articles

Analysis of drug resistance in pulmonary tuberculosis patients with positive sputum tuberculosis culture in Northeast China

Optimizing tylosin dosage for co-infection of Actinobacillus pleuropneumoniae and Pasteurella multocida in pigs using pharmacokinetic/pharmacodynamic modeling

Editorial: Re-emergence of neglected tropical diseases amid the COVID-19 pandemic: epidemiology, transmission, mitigation strategies, and recent advances in chemotherapy and vaccines

Recent insights about pyrrolidine core skeletons in pharmacology

Treatment of non-tuberculosis mycobacteria skin infections

Efficacy and safety evaluation of Azvudine in the prospective treatment of COVID-19 based on four phase III clinical trials

Bryum billardieri Schwaegr. against EV71 infection: in vitro and in vivo antiviral effects, identification of molecular mechanisms and active monomers

Evaluation of the effect of direct-acting antiviral agents on melatonin level and lipid peroxidation in chronic hepatitis C patients

The brief overview, antivirus and anti-SARS-CoV-2 activity, quantitative methods, and pharmacokinetics of cepharanthine: a potential small-molecule drug against COVID-19

Navigating drug repurposing for Chagas disease: advances, challenges, and opportunities

Individualized antibiotic dosage regimens for patients with augmented renal clearance

Effectiveness of vonoprazan-based regimens compared with proton pump inhibitor-based regimens as first-line Helicobacter pylori agents

Can BioSAXS detect ultrastructural changes of antifungal compounds in Candida albicans?–an exploratory study

Editorial: Global excellence in pharmacology of infectious diseases: Australia and Asia

Editorial: Reviews in pharmacology of infectious diseases: 2022

Evaluation of safety and effectiveness of remdesivir in treating COVID-19 patients after emergency use authorization study